Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Read more about Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets. Read more about Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets.
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Read more about Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance. Read more about Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.
STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection. Read more about STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection.
Orientation-dependent Dxz4 contacts shape the 3D structure of the inactive X chromosome. Read more about Orientation-dependent Dxz4 contacts shape the 3D structure of the inactive X chromosome.
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Read more about Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Read more about A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Read more about Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer. Read more about Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.
